Back to search
FDAFDA · Food and drugs·Recall number Z-0607-2018

Synvisc-One ¿ (hylan G-F 20), 6mL delivered from a 10mL syringe Product Usage: A elastoviscous high molecular weight fluid containing hylan A and hylan B polymers produced from chicken combs. Synvisc-One is administered as a single intra-articular injection. Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen.

Published February 21, 2018 · Recall initiated: December 11, 2017

Summary

FDA records medical device Class II recall Z-0607-2018, published February 21, 2018 and initiated December 11, 2017. Recalling firm: Sanofi Genzyme; Status: Terminated; Reported quantity: 12,380 units; Lot: Lot Number: 7RSL021 Expiration Date: 2020-05-31. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Contamination with Methylbacterium thiocyanatum

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Sanofi Genzyme
Distributor
US Nationwide distribution(36 states)
Lot
Lot Number: 7RSL021 Expiration Date: 2020-05-31
Risk classification
Class II
Area (FDA)
device
Country
United States

Related recalls

Questions about this recall

Was Synvisc-One ¿ (hylan G-F 20), 6mL delivered from a 10mL syringe Product Usage: A elastoviscous high molecular weight fluid containing hylan A and hylan B polymers produced from chicken combs. Synvisc-One is administered as a single intra-articular injection. Synvisc-One is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. recalled?

Yes. FDA published recall Z-0607-2018 on February 21, 2018. Reported hazard: Contamination with Methylbacterium thiocyanatum

What should I do if I have this product?

Voluntary: Firm initiated · Letter